![]() |
|
|
Vol. 282, Issue 2, 1055-1063, 1997
Department of Pharmacology, Temple University School of Medicine,
Philadelphia, Pennsylvania
Intracerebral microdialysis was used to measure changes in the
extracellular level of substance P (SP) released from the
periaqueductal gray (PAG) and the preoptic anterior hypothalamus (POAH)
of freely moving Sprague-Dawley rats after noxious cold stimulation.
Artificial cerebrospinal fluid was perfused into the dialysis probe in
the PAG or POAH and samples were collected every 30 min for 4 hr. SP-like immunoreactivity in the samples was measured by
radioimmunoassay. In the PAG, SP base-line release was 0.43 ± 0.08 fmol/fraction. SP release was increased to 1.3 ± 0.4 fmol/fraction during the first collection period after noxious cold.
Pretreatment with the selective mu opioid receptor agonist
PL017 (0.8-3.4 nmol) or the kappa opioid receptor agonist
dynorphin A1-17 (4.6-9.2 nmol), administered into the PAG by
microinjection, produced dose-related inhibition of the cold-evoked SP
release. Naloxone (10 mg/kg s.c.) administration 10 min before these
opioid agonists reduced the inhibition of SP release. In the POAH, SP
base-line release was 0.45 ± 0.06 fmol/fraction and noxious cold
did not cause any significant change in SP release. Microdialysis of SP
(271 fmol-271 pmol/µl/min, for 30 min) into the PAG, but not the
POAH, induced dose-related analgesia (35-68% MPA) in the cold-water
tail-flick test. However, microdialysis of SP into the POAH or PAG
failed to induce any significant change in body temperature. These data
suggest that 1) SP released from the PAG acts as a neuromodulator to
transmit nociceptive information; 2) opioid receptor agonists can
suppress this information by inhibiting SP release; 3) SP evoked by
noxious cold may have a role in triggering the antinociceptive function of the PAG; and 4) SP does not appear to act as a neuromodulator for
thermoregulatory responses in the POAH.